Once daily 3g mesalamine is the optimal dose for maintaining clinical remission in ulcerative colitis: A double-blind, double-dummy, randomized, controlled, dose-ranging study

  • W. Kruis
  • , L. Jonaitis
  • , J. Pokrotnieks
  • , G. Acute
  • , T.L. Mikhailova
  • , M. Horynski
  • , M. Batovsky
  • , I. Racz
  • , K. Kull
  • , M. Faszczyk
  • , R. Greinwald
  • , R. Mueller

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article numberT1124
Pages (from-to)A489
JournalGastroenterology
Volume134
Issue number4, Suppl.1
DOIs
Publication statusPublished - Apr 2008
Externally publishedYes
EventAnnual Meeting of the American Society for Gastrointestinal Endoscopy (ASGE) "Digestive Disease Week" (DDW 2008) - San Diego, United States
Duration: 17 May 200822 May 2008
https://www.natap.org/2008/DDW/DDW.htm

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this